Orchard Therapeutics plc - ADR

NASDAQ:ORTX   10:36:30 AM EDT
2.84
-0.01 (-0.35%)
Regulatory, Other Pre-Announcement

Orchard Therapeutics Announces Regulatory And Clinical Updates For Lead Gene Therapy Programs

Published: 06/29/2021 11:23 GMT
Orchard Therapeutics plc - ADR (ORTX) - Orchard Therapeutics Announces Regulatory and Clinical Updates for Lead Gene Therapy Programs.
Orchard Therapeutics Plc - Expected Clinical Package for Otl-200 Bla for Mld Using Data From Existing Patients Clarified With FDA.
Orchard Therapeutics Plc - Guidance Obtained on Design of Otl-203 Global Registrational Trial for Mps-ih.
Orchard Therapeutics Plc - Enrollment Goal Met in Otl-201 Poc Trial for Mps-iiia.
Orchard Therapeutics Plc - Updates for Otl-103 Maa and Bla Submission Timelines for Was.
Orchard Therapeutics - Now Expects Maa Submission Timeline Regarding Otl-103 for Was to Shift From 2021 to 2022, Subject to Further Dialogue With Ema.